September, 2017 – McDay is pleased to announce the publication of another article, pitched and drafted by our technical PR staff and writers, alongside a talented CRB Consulting Engineers and GSK group of engineers.
The two organizations collaborated on a project to establish a baseline value for carbon emissions contributions in the biopharma area, and identify process or operational modifications that could effectively reduce that value in future processes and products. This article examines the GSK BPDS (Biopharmaceutical Product Development & Supply) team’s efforts to identify where, in the biopharmaceutical manufacturing process and product value chain, the largest contributors to carbon emissions and water usage exist.
The link to the article can be found at
The hardcopy edition (September/October issue) has not been published yet, and will appear in your office mailbox soon!